Vanguard Portfolio Management
LAB icon

Vanguard Portfolio Management’s Standard BioTools LAB Stock Holding History

Vanguard Portfolio Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Sell
674,733
-1,719,667
-72% -$1.62M ﹤0.01% 3046
2026
Q1 		$2.2M Buy
+2,394,400
New +$2.9M ﹤0.01% 2571

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Portfolio Management's LAB Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Standard BioTools (LAB) stake by 72% in Q2 2026, selling an estimated $1.62M and leaving 674,733 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

Vanguard Portfolio Management first reported a position in LAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.2M in Q1 2026. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Vanguard Portfolio Management held 674,733 shares of Standard BioTools worth $555K as of Q2 2026.
  • Vanguard Portfolio Management sold 1,719,667 Standard BioTools shares in Q2 2026, an estimated $1.62M.
  • Standard BioTools made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3046 holding.
  • Vanguard Portfolio Management first reported a position in Standard BioTools in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Standard BioTools position peaked at $2.2M in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.